Neotame anhydrate polymorphs II: Quantitation and relative physical stability

Pharmaceutical Research

Volumn 19, Issue 9, 2002, Pages 1259-1264

  Dong, Z ^a   Munson, E J ^b,c   Schroeder, S A ^d   Prakash, I ^d   Grant, D J W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b University of Minnesota   (United States)

^c UNIVERSITY OF KANSAS   (United States)

^d NutraSweet Company   (United States)

Author keywords

Enantiotropy; Enthalpy of solution; Intrinsic dissolution rate; Neotame; Polymorphism; Powder X ray diffractometry

Indexed keywords

NEOTAME;

ACCURACY; ARTICLE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; ENTHALPY; HEATING; MELTING POINT; PHASE TRANSITION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TEMPERATURE DEPENDENCE; THERMODYNAMICS; X RAY POWDER DIFFRACTION;

ANHYDRIDES; DIPEPTIDES; DRUG STABILITY; POWDER DIFFRACTION; SOLUBILITY; X-RAY DIFFRACTION;

EID: 0036744847     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020334305038     Document Type: Article

References (17)

1. H. G. Brittain. Polymorphism in Pharmaceutical Solids. Marcel Dekker, New York, 1999.
2. A. Burger and R. Ramberger. On the polymorphism of pharmaceuticals and other molecular crystals. I. Theory of thermodynamic rules. Mikrochim. Acta [Wien] 2:259-271 (1979).
3. A. Burger and R. Ramberger. On the polymorphism of pharmaceuticals and other molecular crystals. II. Applicability of thermodynamic rules. Mikrochim. Acta [Wien] 2:273-316 (1979).
4. A. Burger. Thermodynamic and other aspects of the polymorphism of drugs. Pharm. Int. 3:158-163 (1982).
5. L. Yu. Inferring thermodynamic stability relationship of polymorphs from melting data. J. Pharm. Sci. 84:966-974 (1995).
6. C. H. Gu and D. J. W. Grant. Estimating the relative stability of polymorphs and hydrates from heats of solution and solubility data. J. Pharm. Sci. 90:1277-1287 (2001).
7. R. J. Behme, D. Brooke, R. F. Farney, and T. T. Kensler. Characterization of polymorphism of gepirone hydrochloride. J. Pharm. Sci. 74:1041-1046 (1985).
8. A. Chauvet, J. Masse, J. P. Ribet, D. Bigg, J. M. Autin, J. L. Maurel, J. F. Patoiseau, and J. Jaud. Characterization of polymorphs and solvates of 3-amino-1-(m-trifluoromethylphenyl)-6-methyl-1H-pyridazin-4-one. J. Pharm. Sci. 81:836-841 (1992).
9. C. Nofre and J.-M. Tinti. Method of Preparing a Compound Derived from Aspartame, Useful as a Sweetening Agent. U.S. Patent 5510508, 1996.
10. D. J. Wink, S. A. Schroeder, I. Prakash, K. C. Lam, and A. L. Rheingold. Neotame, an alkylated dipeptide and high intensity sweetener. Acta Crystallogr. C55:1365-1368 (1999).
11. Z. Dong, V. G. Young, Jr., B. E. Padden, S. A. Schroeder, I. Prakash, E. J. Munson, and D. J. W. Grant. Crystal structure and physical characterization of neotame methanol solvate. J. Chem. Crystallogr. 29:967-975 (1999).
12. Z. Dong, B. E. Padden, S. A. Schroeder, E. J. Munson, and D. J. W. Grant. Preparation and characterization of polymorphs of neotame anhydrate. AAPS Pharm. Sci. Suppl. 1:S-182, poster number 2351 (1999).
13. Z. Dong, B. E. Padden, J. Salsbury, S. A. Schroeder, I. Prakash, E. J. Munson, and D. J. W. Grant. Preparation and characterization of polymorphs of neotame anhydrate. AAPS Pharm. Sci. Suppl. 2:poster number 3616 (2000).
14. Z. Dong, D. Zhou, B. E. Padden, J. Salsbury, S. A. Schroeder, I. Prakash, C. A. Wight, E. J. Munson, and D. J. W. Grant. Dehydration of a new dipeptide sweetener, neotame monohydrate. AAPS Pharm. Sci. 2:poster number 3617 (2000).
15. Z. Dong, B. E. Padden, J. S. Salsbury, E. J. Munson, S. A. Schroeder, I. Prakash, and D. J. W. Grant. Neotame anhydrate polymorphs I: Preparation and characterization. Pharm. Res. 19:330-336 (2002).
16. J. H. Collett, J. A. Rees, and N. A. Dickinson. Some parameters decribing the dissolution rate of salicylic acid at controlled pH. J. Pharm. Pharmacol. 24:724-728 (1972).
17. C. Doherty and P. York. Mechanisms of dissolution of frusemide/PVP solid dispersions. Int. J. Pharm. 34:197-205 (1987).